-

GE HealthCare expands the LOGIQ e ultrasound platform with new LOGIQ e family

  • LOGIQ™ e Xi and LOGIQ™ e Si offer console-quality ultrasound in a compact laptop-sized system anywhere care can be deliveredii

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced the introduction of the LOGIQ™ e family, featuring LOGIQ™ e Xi and LOGIQ™ e Si, two compact laptop ultrasound systems designed to help clinicians deliver simple, fast, and confident ultrasound imaging where it’s needed across care settings.ii Building on the legacy of LOGIQ e, the LOGIQ e family pairs a reliable console-level performance with a compact, intuitive design combining AI-powered featuresiii and workflow tools that support portability and flexibility for care beyond traditional imaging departments.

“Healthcare delivery is changing rapidly, and imaging technology must evolve with it. Clinicians today need imaging solutions that can move seamlessly across care settings while supporting a variety of users and clinical applications,” said Karley Yoder, CEO, Ultrasound Solutions, Advanced Imaging Solutions, GE HealthCare. “The LOGIQ e family furthers our ability to serve customers with solutions that balance portability, performance and workflow, while bringing the right imaging capabilities to the right clinical environments.”

The LOGIQ e family supports a broad range of clinical applications including multi-purpose imaging, musculoskeletal, emergency medicine, critical care, rheumatology and anesthesiology. LOGIQ e Xi is a premium offering that combines AI-powered tools, advanced imaging capabilities and workflow-enhancing features, while LOGIQ e Si provides essential imaging capabilities in an intuitive, reliable system at a more affordable price point. Together, the systems give clinicians new options built to support a range of user preferences and operational requirements.

To help clinicians keep pace in busy environments, the LOGIQ e family features workflow tools like Scan Assistantiii and Voice Control, to help reduce manual interactions and increase efficiency. Depending on configuration and region, LOGIQ e Xi also includes AI-powered tools designed to assist clinicians with image acquisition and workflow efficiency during exams:

  • Nerveblox™iv labels anatomical landmarks in the ultrasound image, designed to help clinicians feel confident during the peripheral nerve block procedure.
  • MSK Gov assists clinicians in performing musculoskeletal ultrasound examinations, identifying anatomical structures on the ultrasound images acquired.

The ultrasound system also offers new tools to help enhance clinician confidence:

  • B-Flow provides real-time, high-resolution imaging of blood flow.
  • Speckle Reduction Imaging (SRI)-HD enhances visibility of organs and lesions with high-definition contrast resolution.
  • Automated Function Imaging (AFI)iii assesses structural heart defects of the left ventricle, right ventricle and left atrium throughout the heart cycle.
  • SonoBiometry performs measurements of fetal head, abdomen and femur, reducing keystrokes and improving workflow efficiency in biometry exams.

Verisound™ digital tools are also available depending on product configuration and region. Verisound Fleet, a cloud-based fleet management solution, supports organizations managing multiple systems with remote system configuration and backup, fleet-wide deployment capabilities. Verisound Collabvi enables virtual collaboration, and real-time system usage collaboration that lets clinicians easily communicate and collaborate within their network. LOGIQ e Xi also supports Vscan Air™ probe compatibility, giving clinicians added flexibility with wireless, cable-free scanning.

“As I work in different clinics, a portable device is essential for me. What first caught my attention with the LOGIQ e is its design but beyond it being appealing is its performance, it’s very practical, easy to use and simple,” said Dr. Vicente Roqués Escolor, anesthesiologist. “I was also impressed by the possibility of using artificial intelligence, specifically the Nerveblox tool, which allows the scouting of the different structures we see in a large number of regional anesthesia techniques before performing the intervention.”

The latest LOGIQ e ultrasound systems are 510(k) cleared and CE Marked. These ultrasound systems are available in other markets where regulatory approval has been granted. For more information on LOGIQ e family, visit: https://www.gehealthcare.com/en/products/ultrasound/point-of-care-ultrasound/logiq-e-ultrasound and https://www.gehealthcare.com/en/products/ultrasound/versana/logiq-e-s.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Advanced Imaging Solutions, Pharmaceutical Diagnostics and Patient Care Solutions segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.

i LOGIQ e X and LOGIQ e S are marketing representations of the LOGIQ e product; feature availability may vary depending on region.
ii The device is intended for use in professional healthcare facilities. Use is restricted to environmental properties described in the user manual.
iii Only available on LOGIQ e X.
iv Nerveblox is a trademark of Smart Alfa Teknoloji San. ve Tic. A.S.
v MSK Go is powered by SmartAlpha.
vi Not for diagnostic use.

Contacts

GE HealthCare Media Contact:
Eric Tatro
M +1 312 459 6140
eric.tatro@gehealthcare.com

GE HealthCare Technologies Inc.

NASDAQ:GEHC

Release Versions

Contacts

GE HealthCare Media Contact:
Eric Tatro
M +1 312 459 6140
eric.tatro@gehealthcare.com

More News From GE HealthCare Technologies Inc.

GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today introduced Allia™ Celeo,* a ceiling-mounted image guiding system, at the Transcatheter Cardiovascular Therapeutics (TCT) 2026 conference in San Diego. Developed around the principle of smooth procedural flow and built for interventional suites that prioritize high patient throughput and versatility across many indications, Allia Celeo pairs an extra-wide-bore C-arm with intuitive user interface, an AI-powered image chain, and compatib...

GE HealthCare reports third quarter 2026 financial results

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2026. GE HealthCare President and CEO Peter Arduini said, “We delivered strong top-line growth and margin expansion across all segments, and robust EPS growth in the third quarter. This reflects our teams’ commercial execution, disciplined operational focus enabled by Heartbeat, and continued customer adoption of our innovations. With our improved performance year-to...

GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging

CHICAGO & VIENNA--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a global clinical evaluation program spanning three continents and five internationally recognized institutions to assess StarGuide™ GX,i its next-generation digital 4D SPECT/CT system. Participating institutions include Hadassah Medical Center in Israel; Mayo Clinic in the United States; Oncopole Claudius Regaud – Institut Universitaire du Cancer de Toulouse in France; Peking University First Hospital in China; and...
Back to Newsroom